Cisplatin sensitization by concurrent mild hyperthermia in parental and mutant cell lines deficient in homologous recombination and non-homologous endjoining repair

Oncology Reports

Volumn 14, Issue 1, 2005, Pages 281-285

  Raaphorst, G P ^a   Li, L F ^a   Yang, D P ^a   Leblanc, J M ^a  

^a OTTAWA REGIONAL CANCER CENTRE   (Canada)

Author keywords

Cisplatin sensitization; Hyperthermia; Non homologous endjoining repair

Indexed keywords

ANTINEOPLASTIC AGENT; CELL NUCLEUS ANTIGEN; CISPLATIN; DNA BINDING PROTEIN; KU ANTIGEN; X RAY REPAIR CROSS COMPLEMENTING PROTEIN 3; X-RAY REPAIR CROSS COMPLEMENTING PROTEIN 3;

ANIMAL; ARTICLE; CELL LINE; CELL SURVIVAL; CHO CELL; COMPARATIVE STUDY; CRICETULUS; DNA REPAIR; DOSE RESPONSE; DRUG EFFECT; GENETIC RECOMBINATION; GENETICS; HAMSTER; HEAT; MOUSE; MOUSE MUTANT; MUTATION; TIME;

ANIMALS; ANTIGENS, NUCLEAR; ANTINEOPLASTIC AGENTS; CELL LINE; CELL SURVIVAL; CHO CELLS; CISPLATIN; CRICETINAE; CRICETULUS; DNA REPAIR; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; HEAT; MICE; MICE, KNOCKOUT; MUTATION; RECOMBINATION, GENETIC; TIME FACTORS;

EID: 24644477678     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Muggia FM and Gerrit L: Platinum resistance: Laboratory findings and clinical implications. Stem Cell 11: 182-193, 1993. (Pubitemid 23150936)
2. Canon JL, Humblet Y and Symann M: Resistance to cisplatin: How to deal with the problem? Eur J Cancer 26: 1-3, 1990. (Pubitemid 20121839)
3. Kikuchi Y, Miyauchi M, Kizawa I, Oomori K and Kato K: Establishment of a cisplatin-resistant human ovarian cancer cell line. J Natl Cancer Inst 77: 1181-1185, 1986. (Pubitemid 17005092)
4. Behrens BC, Hilton TC, Masuda H, et al: Characterization of a cisdiaminedichloroplatinum (II) resistant human ovarian cancer cell line and its use in evaluation of platinum analogues. Cancer Res 47: 414-418, 1987. (Pubitemid 17009602)
5. Drewinko B, Barlogie : Cell cycle perturbation effects. In: Antitumour Drug Resistance. Fox and Fox (eds). Springer Verlag, Berlin, p101, 1984.
6. Wallner KE and Li GC: Effect of cisplatin resistance on cellular radiation response. Int J Radiat Oncol 13: 587-591, 1987. (Pubitemid 17069656)
7. Calsou P and Salles B: Role of DNA repair in the mechanisms of cell resistance to alkylating agents and cisplatin. Cancer Chemother Pharmacol 32: 85-89, 1993. (Pubitemid 23131924)
8. Eastman A: Mechanisms of resistance to cisplatin. In: Molecular and Clinical Advances in Anticancer Drug Resistance. Ozols RF (ed). Kluwer Academic Pub, Boston, pp233-249, 1991.
9. Eastman A and Schulte N: Enhanced DNA repair as a mechanism of resistance to cisdiaminedichloroplatinum (II). Biochemistry 27: 4730-4734, 1988.
10. Koberle B, Masters JRW, Hartley JA and Wood RD: Defective repair of cisplatininduced DNA damage caused by reduced XPA protein in testicular germ cell tumours. Curr Biol 9: 273-276, 1999. (Pubitemid 29139312)
11. Fravel HNA, Rawlings C J and Roberts JJ: Invreased sensitivity of UV-repair-deficient human cells to DNA bound platinum products which unlike thmine dimers are not recognized by an endonuclease extracted from Micrococcus Luleus. Mutat Res 51: 121-132, 1978. (Pubitemid 8374829)
12. Dijt FJ, Fichinger-Schepman AMJ, Berenda F and Reedijk J: Formation and repair of cisplatin induced adducts to DNA in cultured normal and repair deficient human fibroblasts. Cancer Res 48: 6058-6062, 1988. (Pubitemid 18266801)
13. Selvakumaran M, Pisarcik DA, Bao R, Yeung AT and Hamilton TC: Enhanced cisplatin cytotoxicity by disturbing the nucleotide excision repair pathway in ovarian cancer cell lines. Cancer Res 63: 1311-1316, 2003. (Pubitemid 36348710)
14. Liu N, Lamerdin JE, Tebbs RS, Schild D, Tucker JD, Shen MR, Brookman KW, Siciliano MJ, Walter CA, Fan W, Narayana LS, Zhou ZQ, Adamson AW, Sorensen KJ, Chen DJ, Jones NJ and Thompson LH: XRCC2 and XRCC3 new human Rad 51-family members promote chromosome stability and protect against DNA cross links and other damages. Mol Cell 1: 783-793, 1998. (Pubitemid 128379063)
15. Raaphorst GP, Leblanc JM, Yang DP and Li LF: Comparison of response to cisplatin radiation and combined treatment in cell lines deficient in recombination repair. Anticancer Res (In press).
16. Takata M, Sasaki MS, Sonoda E, Morrison C, Hasimoto M, Utsumi H, et al: Homologous recombination and nonhomologous end-joining pathways of DNA double-strand break repair have overlapping roles in the maintenance of chromosomal integrity in vertebrate cells. EMBO J 17: 5497-5508, 1998. (Pubitemid 28427063)
17. Urano M and Douple E (eds.): Biology of Thermal Potentiation of Radiotherapy. In: Hyperthermia and Oncology. Vol. 2. Utrecht VSP, 1989.
18. Urano M and Douple E (eds.): Chemopotentiation by hyperthermia. In: Hyperthermia and Oncology. Vol. 4. Utrecht VSP, 1994.
19. Raaphorst GP: Thermal radiosensitization in vitro: In: Hyperthermia and Oncology. Urano M, Douple E (eds). Vol. 2. Utrecht VSP, pp17-51, 1989.
20. Wong RSL, Dynlacht JR, Cedervall B and Dewey WC: Analysis by pulsed field gel electrophoresis of DNA double strand breaks induced by heat and/or x-irradiation in bulk and replicating DNA of CHO cells. Int J Radiat Biol 68: 141-152, 1995.
21. Raaphorst GP: Recovery of sublethal radiation damage and its inhibition by hyperthermia in normal and transformed mouse cells. Int J Radiat Oncol 22: 1035-1041, 1992.
22. Armour EP and Raaphorst GP: Long duration mild hyperthermia in brachytherapy. Int J Hyperthermia 20: 175-189, 2004. (Pubitemid 38425515)
23. Ben Hur E, Elkind MM and Bronk BV: Thermally enhanced radioresponses of cultured Chinese hamster cells (Inhibition of repair of sublethal damage and enhancement of lethal damage). Radiat Res 58: 38-51, 1974.
24. Burgman P, Ouyang H, Peterson S, Chen DJ and Li GC: Heat inactivation of Ku autoantigen: Possible role in hyperthermic radiosensitization. Cancer Res 57: 2847-2850, 1997. (Pubitemid 27315025)
25. Myint WK, Ng C and Raaphorst GP: Examining the nonhomologous repair process in cisplatin and radiation treatments. Int J Radiat Biol 78: 417-424, 2003. (Pubitemid 34496892)
26. Pierce AJ, Johnson RD, Thompson LH and Jasin M: XRCC3 promotes homologydirected repair of DNA damage in mammalian cells. Genes Dev 13: 2633-2638, 1999. (Pubitemid 29508550)
27. Klein ME, Frayer K and Bachur K: Hyperthermic enhancement of chemotherapeutic agent in L1210 leukemia. Blood 50: 110-133, 1977.
28. Hettinga JVE, Lemstra W, Meijer C, et al: Hyperthermic potentiation of cisplatin toxicity in human small cell lung carcinoma cell line and a cisplatin resistant subline. Int J Hypertherm 10: 795-805, 1994. (Pubitemid 24352987)
29. Raaphorst GP, Miao J, Stewart DJ and Ng CE: Concomitant treatment with mild hyperthermia, cisplatin and low dose rate irradiation in human ovarian cells sensitive and resistant to cisplatin. Oncol Rep 5: 971-978, 1998.
30. Kubuta N, Kakehi M and Inada T: Hyperthermia enhancement of cell killing by five platinum complexes in human malignant melanoma cells grown as monolayer cultures and multicellular spheroids. Int J Radiat Oncol 25: 491-497, 1993. (Pubitemid 23068716)
31. Konings AWT, Hettinga JVE, Lemstra W, Humphrey GB and Kapinga HH: Sensitizing for cisplatin action by hyperthermia in resistant cells. Int J Hypertherm 9: 553-562, 1993. (Pubitemid 23217200)
32. Hettinga JVE, Konings SWT and Kampinga HH: Reduction of cellular cisplatin resistance by hyperthermia - a review. Int J Hypertherm 13: 439-457, 1997. (Pubitemid 27460146)
33. Dewit L: Combined treatment of radiation and cis-diaminedichloroplatinum (II): A review of experimental and clinical data. Int J Radiat Oncol 13: 403-426, 1987.
34. Herman TS, Sweets CC, White DM and Gerner EW: Effect of heating on lethality due to hyperthermia and selected chemotherapeutic drugs. J Natl Cancer Int 68: 487-491, 1982. (Pubitemid 12156688)
35. Neilan BA, Henie KJ, Nagle WA and Moss AJ: Cytotoxicity of hyperthermia combined with bleomycin or cisplatinum in cultured RIF cells: modification by thermotolerance polyhydroxy compounds. Cancer Res 46: 2245-2247, 1986. (Pubitemid 16120674)